You are increasing the chance of a serious bleed putting someone on a clopidogrel [Plavix].
There’s always a tradeoff between thrombosis and bleeding with any anticoagulant or antiplatelet drug. However, given what we now know about Iclusig’s side effects, I would expect the addition of a antiplatelet drug to provide a net benefit on the whole.
That increase in 11% in thrombosis might be a certain subpopulation if you argue the bleeding risk is neutralized.
I do not understand this sentence—please clarify.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”